This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medipost Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Minju Lee and a Patent for Cartilage-Damage Treatment.
Introduction
Minju Lee is an inventor associated with Seongnam, South Korea, and Medipost Co., Ltd. His patent work concerns a pharmaceutical approach to cartilage damage-associated diseases.
Latest Patents
Lee is associated with 1 patent, titled “Pharmaceutical Composition Comprising Hyaluronic Acid and Stem Cells for Treating Cartilage Damage-Associated Disease.” The patent describes a composition involving hyaluronic acid and mesenchymal stem cells. It also describes administering hyaluronic acid before the stem cells, rather than giving them together as a mixture. According to the patent description, this sequence may better alleviate symptoms in arthritic joint tissues and reduce the load on knees caused by body weight.
Career Highlights
Lee’s listed patent reflects research into the potential therapeutic use of hyaluronic acid and mesenchymal stem cells for cartilage-related conditions. His company affiliation is Medipost Co., Ltd.
Collaborations
Yun Sun Yang is identified as Lee’s coworker. The patent description focuses on a treatment approach that may support the management of cartilage damage-associated diseases.
Conclusion
Minju Lee’s patent highlights a proposed treatment strategy that sequences hyaluronic acid and mesenchymal stem cell administration to address cartilage damage-associated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile